Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms SJF-6683 |
Target |
Action inhibitors |
Mechanism MAPK13 inhibitors(mitogen-activated protein kinase 13 inhibitors), Proteolysis |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC62H63F2N7O12S |
InChIKeyLYUUIIZKBMBNQV-CHOFKVETSA-N |
CAS Registry2254609-23-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | United States | 10 Jan 2019 | |
Breast Cancer | Preclinical | United States | 10 Jan 2019 |